Skip to main content
Erschienen in: Supportive Care in Cancer 3/2008

01.03.2008 | Original Article

Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma

verfasst von: Haidy Lee, Carole Havrila, Vikki Bravo, Kellie Shantz, Kellie Diaz, James Larner, Paul Read

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Goals

Malnutrition in the head and neck cancer population is a widely recognized factor contributing to negative outcomes. The goal of this study was to determine if providing complimentary oral nutritional supplementation for patients undergoing definitive radiation therapy for oropharyngeal carcinoma reduced weight loss and the need for percutaneous endoscopic gastrostomy (PEG) tube placement.

Materials and methods

The data from 79 patients undergoing radiotherapy for oropharyngeal cancer were extracted and analyzed retrospectively from an institutional Human Investigation Committee approved database for the study of advanced radiation therapy techniques for head and neck cancer. Forty patients were treated before the initiation of a nutritional supplementation program, and 39 patients received supplementation. Patients were stratified by type of treatment (radiation alone or chemoradiation) and whether or not they had a PEG tube.

Results

All patient groups receiving supplementation manifested a significant decrease in weight loss compared to those who did not receive it. Nutritional supplementation was associated with a 40% relative reduction in weight loss in patients treated with radiotherapy alone (6.1 vs 10.1%, p = 0.008) and a 37% reduction in weight loss in patients treated with chemoradiotherapy (6.7 vs 10.7%, p = 0.007). When patients were stratified by the presence or absence of a PEG tube, both groups experienced a 39% relative reduction in weight loss (with PEG, 5.7 vs 9.3%, p = 0.028; without PEG, 6.9 vs 11.2%, p = 0.002). Supplementation was associated with a decreased need for PEG tube placement (31% decreased to 6%) in patients treated with radiotherapy alone.

Conclusions

Providing complimentary oral nutritional supplementation significantly decreases weight loss and the need for PEG tube placement in patients undergoing radiation therapy for oropharyngeal cancer.
Literatur
1.
Zurück zum Zitat Baredes S, Behin D, Deitch E (2004) Percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer. Ear Nose Throat J 83(6):417–419PubMed Baredes S, Behin D, Deitch E (2004) Percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer. Ear Nose Throat J 83(6):417–419PubMed
2.
Zurück zum Zitat Brookes GB (1985) Nutritional status-a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg 93(1):69–74PubMed Brookes GB (1985) Nutritional status-a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg 93(1):69–74PubMed
3.
Zurück zum Zitat Callahan CM, Buchanan NN, Stump TE (2001) Healthcare costs associated with percutaneous endoscopic gastrostomy among older adults in a defined community. J Am Geriatr Soc 49(11):1525–1529PubMedCrossRef Callahan CM, Buchanan NN, Stump TE (2001) Healthcare costs associated with percutaneous endoscopic gastrostomy among older adults in a defined community. J Am Geriatr Soc 49(11):1525–1529PubMedCrossRef
4.
Zurück zum Zitat Cruz I, Mamel JJ, Brady PG, Cass-Garcia M (2005) Incidence of abdominal wall metastasis complicating PEG tube placement in untreated head and neck cancer. Gastrointest Endosc 62(5):708–711PubMedCrossRef Cruz I, Mamel JJ, Brady PG, Cass-Garcia M (2005) Incidence of abdominal wall metastasis complicating PEG tube placement in untreated head and neck cancer. Gastrointest Endosc 62(5):708–711PubMedCrossRef
5.
Zurück zum Zitat Ehrsson YT, Languis-Eklof A, Bark T, Laurell G (2004) Percutaneous endoscopic gastrostomy (PEG)—a long term follow-up study in head and neck cancer patients. Clin Otolaryngol Allied Sci 29(6):740–746PubMedCrossRef Ehrsson YT, Languis-Eklof A, Bark T, Laurell G (2004) Percutaneous endoscopic gastrostomy (PEG)—a long term follow-up study in head and neck cancer patients. Clin Otolaryngol Allied Sci 29(6):740–746PubMedCrossRef
6.
Zurück zum Zitat Fietkau R (2000) Nutritional support of patients during radiotherapy. In: Mason JB, Nitenberg G (eds) Cancer and nutrition: prevention and treatment. Nestle Nutrition Workshop Series Clinical Performance Program. Karger, Basel 4:225–238 Fietkau R (2000) Nutritional support of patients during radiotherapy. In: Mason JB, Nitenberg G (eds) Cancer and nutrition: prevention and treatment. Nestle Nutrition Workshop Series Clinical Performance Program. Karger, Basel 4:225–238
7.
Zurück zum Zitat Hearne BE, Dunaj JM, Daly JM et al (1985) Enteral nutrition support in head and neck cancer: tube vs oral feeding during radiation therapy. J Am Diet Assoc 85(6):669–674PubMed Hearne BE, Dunaj JM, Daly JM et al (1985) Enteral nutrition support in head and neck cancer: tube vs oral feeding during radiation therapy. J Am Diet Assoc 85(6):669–674PubMed
8.
Zurück zum Zitat Isenring E, Capra S, Bauer J (2004) Patient satisfaction is rated higher by radiation oncology outpatients receiving nutritional intervention compared with usual care. J Hum Nutr Diet 17(2):145–152PubMedCrossRef Isenring E, Capra S, Bauer J (2004) Patient satisfaction is rated higher by radiation oncology outpatients receiving nutritional intervention compared with usual care. J Hum Nutr Diet 17(2):145–152PubMedCrossRef
9.
Zurück zum Zitat Isenring EA, Capra S, Bauer JD (2004) Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 91:447–452PubMedCrossRef Isenring EA, Capra S, Bauer JD (2004) Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 91:447–452PubMedCrossRef
10.
Zurück zum Zitat Larsson M, Hedelin B, Johansson I, Athlin E (2005) Eating problems and weight loss for patients with head and neck cancer. Cancer Nursing 28(6):425–435PubMedCrossRef Larsson M, Hedelin B, Johansson I, Athlin E (2005) Eating problems and weight loss for patients with head and neck cancer. Cancer Nursing 28(6):425–435PubMedCrossRef
11.
Zurück zum Zitat McCarthy D, Weihofen D (1999) The effect of nutritional supplements on food intake in patients undergoing radiotherapy. Oncol Nurs Forum 26(5):897–900PubMed McCarthy D, Weihofen D (1999) The effect of nutritional supplements on food intake in patients undergoing radiotherapy. Oncol Nurs Forum 26(5):897–900PubMed
12.
Zurück zum Zitat Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P (2001) Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube. Cancer 91(9):1785–1790PubMedCrossRef Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P (2001) Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube. Cancer 91(9):1785–1790PubMedCrossRef
13.
Zurück zum Zitat Nayel H, el-Ghoneimy E, el-Haddad S (1992) Impact of nutritional supplementation on treatment delay and morbidity in patients with head and neck tumors treated with irradiation. Nutrition 8(1):13–18PubMed Nayel H, el-Ghoneimy E, el-Haddad S (1992) Impact of nutritional supplementation on treatment delay and morbidity in patients with head and neck tumors treated with irradiation. Nutrition 8(1):13–18PubMed
14.
Zurück zum Zitat Ollenschlanger G, Viell B, Thomas W et al (1991) Tumor anorexia: causes, assessment, treatment. Recent Results Cancer Research 121:249–259 Ollenschlanger G, Viell B, Thomas W et al (1991) Tumor anorexia: causes, assessment, treatment. Recent Results Cancer Research 121:249–259
15.
Zurück zum Zitat Ottery FD (1995) Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 22(2):98–111PubMed Ottery FD (1995) Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 22(2):98–111PubMed
16.
Zurück zum Zitat Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2003) Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol (R Coll Radiol) 15(8):443–450 Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2003) Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol (R Coll Radiol) 15(8):443–450
17.
Zurück zum Zitat Ravasco P, Monteiro-Grillo I, Camilo ME (2003) Does nutrition influence quality of life in cancer patients undergoing radiotherapy. Radiot Oncol 67:213–220CrossRef Ravasco P, Monteiro-Grillo I, Camilo ME (2003) Does nutrition influence quality of life in cancer patients undergoing radiotherapy. Radiot Oncol 67:213–220CrossRef
18.
Zurück zum Zitat Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME (2005) Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 27(8):659–668PubMedCrossRef Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME (2005) Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 27(8):659–668PubMedCrossRef
19.
Zurück zum Zitat Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2005) Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23:1431–1438PubMedCrossRef Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME (2005) Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23:1431–1438PubMedCrossRef
20.
Zurück zum Zitat Raynor EM, Williams MF, Martindale RG, Porubsky ES (1999) Timing of percutaneous endoscopic gastrostomy tube placement in head and neck cancer patients. Otolaryngol Head Neck Surg 120(4):479–482PubMedCrossRef Raynor EM, Williams MF, Martindale RG, Porubsky ES (1999) Timing of percutaneous endoscopic gastrostomy tube placement in head and neck cancer patients. Otolaryngol Head Neck Surg 120(4):479–482PubMedCrossRef
21.
Zurück zum Zitat Rickman J (1998) Percutaneous endoscopic gastrostomy: psychological effects. Br J Nurs 7(12):723–729PubMed Rickman J (1998) Percutaneous endoscopic gastrostomy: psychological effects. Br J Nurs 7(12):723–729PubMed
22.
Zurück zum Zitat Stern JM, Bremmer B, Moinpour CM, Sullivan KM, Lenssen P, Aker SN (2000) Impact of a randomized, controlled trial of liberal vs conservative hospital discharge criteria on energy, protein, and fluid intake in patients who received marrow transplants. J Amer Diet Assoc 100(9):1015–1022CrossRef Stern JM, Bremmer B, Moinpour CM, Sullivan KM, Lenssen P, Aker SN (2000) Impact of a randomized, controlled trial of liberal vs conservative hospital discharge criteria on energy, protein, and fluid intake in patients who received marrow transplants. J Amer Diet Assoc 100(9):1015–1022CrossRef
23.
Zurück zum Zitat Toomey D, Redmond HP, Bouchier-Hayes D (1995) Mechanisms mediating cancer cachexia. Cancer 76(12):2418–2426PubMedCrossRef Toomey D, Redmond HP, Bouchier-Hayes D (1995) Mechanisms mediating cancer cachexia. Cancer 76(12):2418–2426PubMedCrossRef
24.
Zurück zum Zitat van Bokhorst-de van der Schuer MA, von Blomberg-van der Flier BM, Riezebos RK et al (1998) Differences in immune status between well-nourished and malnourished head and neck cancer patients. Clin Nutr 17(3):107–111PubMedCrossRef van Bokhorst-de van der Schuer MA, von Blomberg-van der Flier BM, Riezebos RK et al (1998) Differences in immune status between well-nourished and malnourished head and neck cancer patients. Clin Nutr 17(3):107–111PubMedCrossRef
25.
Zurück zum Zitat van Bokhorst-de van der Schuer MA, van Leeuwen PA, Kuik DJ et al (1999) The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 86(3):519–527PubMedCrossRef van Bokhorst-de van der Schuer MA, van Leeuwen PA, Kuik DJ et al (1999) The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 86(3):519–527PubMedCrossRef
26.
Zurück zum Zitat Whitman MM (2000) The starving patient: supportive care for people with cancer. Clin J Oncol Nurs 4:121–125PubMed Whitman MM (2000) The starving patient: supportive care for people with cancer. Clin J Oncol Nurs 4:121–125PubMed
Metadaten
Titel
Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma
verfasst von
Haidy Lee
Carole Havrila
Vikki Bravo
Kellie Shantz
Kellie Diaz
James Larner
Paul Read
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2008
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0313-0

Weitere Artikel der Ausgabe 3/2008

Supportive Care in Cancer 3/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.